Marcadores de desdiferenciación podocitaria en un paciente con glomerulonefritis colapsante

Espinosa Hernández, M; Romera Segorbe, A; Moyano Peregrín, C; López Andreu, M; Redondo Pachón, M. D; Aljama García, P; Ortega Salas, R; González Menchén, A; Pérez-Seoane, C; López Rubio, F.
Nefrología (Madr.) ; 30(3): 360-366, mayo-jun. 2010. ilus, tab
Artículo en Español | IBECS (España) | ID: ibc-104565

Documentos relacionados

  1. Comparison between outcomes of IgA nephropathy with nephrotic-range proteinuria and nephrotic syndrome: do podocytes play a role?
  2. Podocyte Infolding Glomerulopathy (PIG) in a Patient With Undifferentiated Connective Tissue Disease: A Case Report.
  3. Proteinuria in thrombotic microangiopathy is associated with partial podocytopathy.
  4. Focal segmental glomerulosclerosis and proteinuria associated with Myo1E mutations: novel variants and histological phenotype analysis.
  5. HBx promotes glomerular podocyte-induced immune cell responses.
  6. Hantavirus infection with severe proteinuria and podocyte foot-process effacement.
  7. Podocyte-specific silencing of acid sphingomyelinase gene to abrogate hyperhomocysteinemia-induced NLRP3 inflammasome activation and glomerular inflammation.
  8. Microtubule associated protein 4 phosphorylation-induced epithelial-to-mesenchymal transition of podocyte leads to proteinuria in diabetic nephropathy.
  9. The role of podocytes in lupus nephritis: Insights and implications.
  10. Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group.